These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8536337)

  • 1. Synthesis of a novel dual inhibitor of thromboxane A2 synthetase and 5-lipoxygenase (E3040) via the direct coupling reaction of hydroquinone with 3-pyridinecarboxaldehyde.
    Komatsu Y; Minami N
    Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1614-6. PubMed ID: 8536337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production.
    Oketani K; Nagakura N; Harada K; Inoue T
    Eur J Pharmacol; 2001 Jun; 422(1-3):209-16. PubMed ID: 11430933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel dual inhibitors of 5-lipoxygenase and thromboxane A2 synthetase: synthesis and structure-activity relationships of 3-pyridylmethyl-substituted 2-amino-6-hydroxybenzothiazole derivatives.
    Hibi S; Okamoto Y; Tagami K; Numata H; Kobayashi N; Shinoda M; Kawahara T; Murakami M; Oketani K; Inoue T
    J Med Chem; 1994 Sep; 37(19):3062-70. PubMed ID: 7932529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon.
    Sakai H; Suzuki T; Murota M; Oketani K; Uchiumi T; Murakami M; Takeguchi N
    Br J Pharmacol; 2002 Jun; 136(3):383-90. PubMed ID: 12023941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of E3040, an inhibitor of 5-lipoxygenase and thromboxane synthase, on rat bowel damage induced by lipopolysaccharide.
    Oketani K; Inoue T; Murakami M
    Eur J Pharmacol; 2001 Sep; 427(2):159-66. PubMed ID: 11557269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different biliary excretion systems for glucuronide and sulfate of a model compound; study using Eisai hyperbilirubinemic rats.
    Takenaka O; Horie T; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1362-9. PubMed ID: 7562509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of (E)-3-(1,4-benzoquinonyl)-2-[(3-pyridyl)-alkyl]-2-propenoic acid derivatives that inhibit both 5-lipoxygenase and thromboxane A2 synthetase.
    Hibi S; Okamoto Y; Tagami K; Numata H; Kobayashi N; Shinoda M; Kawahara T; Harada K; Miyamoto K; Yamatsu I
    J Med Chem; 1996 Aug; 39(16):3148-57. PubMed ID: 8759636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier-mediated active transport of the glucuronide and sulfate of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) into rat liver: quantitative comparison of permeability in isolated hepatocytes, perfused liver and liver in vivo.
    Takenaka O; Horie T; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Feb; 280(2):948-58. PubMed ID: 9023311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the uricosuric action of the anti-inflammatory drug E3040 used to treat inflammatory bowel disease I: study using a rat model of hyperuricemia.
    Yamada H; Kotaki H; Furitsu H; Sawada Y; Iga T
    Biopharm Drug Dispos; 1999 Mar; 20(2):77-83. PubMed ID: 10206322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. 2. 4-(3-Pyridyl)-1(2H)-phthalazinones.
    Yamaguchi M; Kamei K; Koga T; Akima M; Maruyama A; Kuroki T; Ohi N
    J Med Chem; 1993 Dec; 36(25):4061-8. PubMed ID: 8258828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E 3040.
    Drugs R D; 1999 Mar; 1(3):256-7. PubMed ID: 10566039
    [No Abstract]   [Full Text] [Related]  

  • 12. Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives.
    Ohkawa S; Terao S; Terashita Z; Shibouta Y; Nishikawa K
    J Med Chem; 1991 Jan; 34(1):267-76. PubMed ID: 1992126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [2-Aryl-pyrrolo[2,1-b]benzothiazoles as a selective or dual inhibitors of cyclo-oxygenases and 5-lipoxygenases. 21. Non-steroidal anti-inflammatory agents].
    Dannhardt G; Kreher M; Nowe U; Schmitt S
    Pharmazie; 1997 Jun; 52(6):428-36. PubMed ID: 9324689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of anti-inflammatory bowel disease drug, E3040, on urate transport in rat renal brush border membrane vesicles.
    Yamada H; Kotaki H; Itoh T; Sawada Y; Iga T
    Eur J Pharmacol; 2000 Oct; 406(1):45-8. PubMed ID: 11011031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tröger's base. An alternate synthesis and a structural analog with thromboxane A2 synthetase inhibitory activity.
    Johnson RA; Gorman RR; Wnuk RJ; Crittenden NJ; Aiken JW
    J Med Chem; 1993 Oct; 36(21):3202-6. PubMed ID: 8230108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboxane synthetase inhibitors (TXSI). Design, synthesis, and evaluation of a novel series of omega-pyridylalkenoic acids.
    Kato K; Ohkawa S; Terao S; Terashita Z; Nishikawa K
    J Med Chem; 1985 Mar; 28(3):287-94. PubMed ID: 4038746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors.
    Soyka R; Guth BD; Weisenberger HM; Luger P; Müller TH
    J Med Chem; 1999 Apr; 42(7):1235-49. PubMed ID: 10197967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzothiazole hydroxy ureas as inhibitors of 5-lipoxygenase: use of the hydroxyurea moiety as a replacement for hydroxamic acid.
    Greco MN; Hageman WE; Powell ET; Tighe JJ; Persico FJ
    J Med Chem; 1992 Aug; 35(17):3180-3. PubMed ID: 1324317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (E)-7-Phenyl-7-(3-pyridyl)-6-heptenoic acid (CV-4151): a potent, specific thromboxane A2 synthetase inhibitor.
    Nishikawa K; Terashita Z; Imamoto T; Imura Y; Hirata M; Terao S
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():523-5. PubMed ID: 2936160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.